<SEC-DOCUMENT>0001104659-24-009446-index.html : 20240201
<SEC-HEADER>0001104659-24-009446.hdr.sgml : 20240201
<ACCEPTANCE-DATETIME>20240201160520
ACCESSION NUMBER:		0001104659-24-009446
CONFORMED SUBMISSION TYPE:	S-3
PUBLIC DOCUMENT COUNT:		5
FILED AS OF DATE:		20240201
DATE AS OF CHANGE:		20240201

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Annovis Bio, Inc.
		CENTRAL INDEX KEY:			0001477845
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		IRS NUMBER:				262540421
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		S-3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-276814
		FILM NUMBER:		24586894

	BUSINESS ADDRESS:	
		STREET 1:		101 LINDENWOOD DRIVE, SUITE 225
		CITY:			MALVERN
		STATE:			PA
		ZIP:			19355
		BUSINESS PHONE:		484-875-3192

	MAIL ADDRESS:	
		STREET 1:		101 LINDENWOOD DRIVE, SUITE 225
		CITY:			MALVERN
		STATE:			PA
		ZIP:			19355

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	QR Pharma, Inc.
		DATE OF NAME CHANGE:	20091202
</SEC-HEADER>
<DOCUMENT>
<TYPE>S-3
<SEQUENCE>1
<FILENAME>tm244399-1_s3.htm
<DESCRIPTION>S-3
<TEXT>
Document 1 - file: tm244399-1_s3.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>lg_annovis-4c.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 2 - file: lg_annovis-4c.jpg

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.5
<SEQUENCE>3
<FILENAME>tm244399d2_ex4-5.htm
<DESCRIPTION>EXHIBIT 4.5
<TEXT>
Document 3 - file: tm244399d2_ex4-5.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>4
<FILENAME>tm244399d2_ex23-1.htm
<DESCRIPTION>EXHIBIT 23.1
<TEXT>
Document 4 - file: tm244399d2_ex23-1.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-FILING FEES
<SEQUENCE>5
<FILENAME>tm244399d2_ex-filingfees.htm
<DESCRIPTION>EX-FILING FEES
<TEXT>
Document 5 - file: tm244399d2_ex-filingfees.htm

</DOCUMENT>
</SEC-DOCUMENT>